Obese people are less likely to survive cancer, and one reason may be a surprising inequality: The overweight are undertreated.
Doctors often short them on chemotherapy by not basing the dose on size, as they should. They use ideal weight or cap the dose out of fear about how much treatment an obese patient can bear. Yet research shows that bigger people handle chemo better than smaller people do.
And this is going on before IPAB gets its grip on all medical spending in this country, and “Death to Fatties!” becomes an unspoken (but whispered) national goal.